Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma
Authors:
Open Access
- 26 June 2014
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 46 (8) , 720-722
Abstract
MicroRNAs (miRNAs) have been demonstrated to involve in multiple biological processes, including apoptosis, proliferation, differentiation, and metastasis [1–3]. In addition, several groups have reported that abnormalities of specific miRNAs are implicated in cancer pathogenesis [4,5]. The roles of miR-224 and miR-145 in tumorigenesis have attracted the attention of many researchers. The protein A disintegrin and metalloproteinase 17 (ADAM17) is over-expressed in many types of cancers, including hepatocellular carcinoma (HCC). ADAM17 expression is regulated by multiple miRNAs, which have been identified in several types of cancers [6,7]. In silico analysis suggested that ADAM17 is a common target of both miR-224 and miR-145. In the present study, we investigated the expression and distribution of miR-224, miR-145, and ADAM17 in HCC samples and analyzed the relationship between both miRNAs and ADAM17.Keywords
This publication has 7 references indexed in Scilit:
- MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma PatientsNeoplasia, 2013
- MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma #Hepatology, 2009
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- The functions of animal microRNAsNature, 2004
- MicroRNAsCell, 2004